NEW YORK (GenomeWeb) – Health plan management firm MagnaCare has signed a deal to provide GenTox's pharmacogenomic testing services to members of its provider network, the companies announced today.

"This initiative promises to provide doctors with the valuable information they need to achieve more efficient dosing of critical medications and provides access to information for the most effective choices based upon each patient’s unique genetic makeup obtained through the testing," MagnaCare CEO Joseph Berardo said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.